Cite
Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses.
MLA
Wu, Shasha, et al. “Comprehensive Analysis of the RSK Gene Family in Acute Myeloid Leukemia Determines a Prognostic Signature for the Prediction of Clinical Prognosis and Treatment Responses.” Hematology, vol. 28, no. 1, Dec. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1080/16078454.2023.2235833.
APA
Wu, S., Jin, J., Huang, J., Chen, G., & Chen, Y. (2023). Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses. Hematology, 28(1), 1–10. https://doi.org/10.1080/16078454.2023.2235833
Chicago
Wu, Shasha, Jiao Jin, Jing Huang, Guifang Chen, and Yan Chen. 2023. “Comprehensive Analysis of the RSK Gene Family in Acute Myeloid Leukemia Determines a Prognostic Signature for the Prediction of Clinical Prognosis and Treatment Responses.” Hematology 28 (1): 1–10. doi:10.1080/16078454.2023.2235833.